TechConnect Innovation Program

Platform technology of Positron Emission Tomography (PET)

Sogang University Research Foundation, Seoul, Korea

TECHNOLOGY SUMMARY

F-18 labeling technology: increasing the conventional production yield of 1% to 40% [18F] FP-CIT: Providing clearer PET images than the conventional SPECT images regarding Parkinson disease FC119S (Alzavue): Developing materials which are selectively bonded to beta-amyloid causing Alzheimer disease to diagnose the disease at its early stages

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Ready to Market

Technology Readiness Level: TRL 9

FIGURES OF MERIT

Value Proposition: to have best Alzheimer imaging radiopharmaceuticals

to have only unique Parkinson imaging radiopharmaceuticals

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 525

Website: http://www.sogang.ac.kr/english/

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: From 2006 to 2012, developing Synthesis of Tracer for Tumor Imaging and Labeling Technology, funded by the Ministry of Health and Welfare of Korea's funding

In 2009, research for commercialization of PET radiopharmaceuticals for diagnosing Alzheimer's dementia disease using the high-speed and high-yield radioactive isotope labeling technology in the Industry-Academia-Research Support Center affiliated to the Seoul Development Institute

From 2009 to 2014, Converging Research Center for PET Radiopharmaceuticals

In 2014, research for commercialization of PET radiopharmaceuticals for diagnosing brain cancer, funded by the National Research Foundation of Korea

Primary Sources of Funding: Corporate Venture Capital

Looking for: Development / License Partners